Back

1 min de lecture

[Press information] XENOTHERA announces the continuation of development of its anti-SARS-CoV-2 antibody.

Auteur
contact@xenothera.com
Publié
11 mars 2022

January 2022.

# Download our press information (english version)

# Télécharger notre information presse (version française)